Published on : Mar 31, 2017
Albany, New York, March 31, 2017: ResearchMoz.us announced the addition of a new research report to its ever-increasing repository. The research report, titled “Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon Valvuloplasty & TMVR), By Region, By Country (2016-2021) - By Region (North America, Europe, Asia Pacific, Rest of the World), By Country (US, Canada, Germany, France, U.K, China, India, Japan, Brazil, Saudi Arabia),” is detailed take on the factors governing the growth of the global market.
According to the research report, the global heart valve devices market is expected to grow at a CAGR of 13.35% between the forecast years of 2016 and 2016. The good growth rate will be attributable to the rising prevalence of cardiovascular diseases and disorders that is threatening lifespan amongst the elderly and the geriatrics. However, the growing pool of geriatrics is projected to be instrumental to the rise of this market as the aged are far more susceptible to the medical issues of the heart than the young. Furthermore, changing lifestyles, which have now become remarkably sedentary, poor dietary habits, and addictions such as smoking and alcoholism have also contributed to the failing hearts, thereby giving the global market an adequate impetus.
Click to get more details with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=1026595
The rising awareness of minimally invasive surgeries along with growing investments in research and development have also augmented the demand for heart valve devices market. The persistent innovations brought in by various players in the global market to strengthen their positions has also given the global market a thorough boost over the past few years. On the basis of technique, the global heart valve devices market is segmented into bioprosthetic valve, mechanical valve, and transcatheter aortic valve replacement (TAVR). Of these, the bioprosthetic valve has remained dominant in the past few years. However, TAVR is expected to surpass its share in the coming years.
Geographically, the global heart valve devices market is segmented into Asia Pacific, North America, Europe, and Rest of the World. The report predicts that Asia Pacific will take the lead due to a large pool of geriatrics and patients. Furthermore, as the developing nations work toward setting up better healthcare infrastructure and provide better medical care, it will fuel the growth of the regional market.
Some of the leading players operating in the global heart valve devices market are JenaValve Technology Inc., Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Medtronic Plc, Abbott Laboratories, St. Jude Medical Inc., CryoLife Inc., Neovasc Inc., LivaNova Plc, and TTK Healthcare. The research report assesses these players in the global market and ascertains the nature of the competitive landscape. The publication also mentions the research and development being conducted by these companies, their expansion strategies, and the impact of these mergers and acquisitions through the years. The research report clearly explains the potential threats due to new entrants making inroads into the market and possibilities of newer opportunities for the players in the market.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on email@example.com